Almirall and Barcelona Supercomputing Center Expand Their Collaboration to Accelerate Innovation in Medical Dermatology

The strategic framework agreement deepens the long-standing partnership, leveraging Artificial Intelligence and High-Performance Computing to identify new opportunities of collaboration in the discovery of new therapies for skin diseases. Almirall joins the ‘BSC Connects’ program to foster public-private collaboration and enhance its R&D capabilities. The alliance strengthens Almirall’s innovation strategy by integrating disruptive technologies to … [Read more…]

Number of Shares and Voting Rights of Innate Pharma as of April 9, 2026

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or “AMF”) General Regulation, Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) releases its total number of shares outstanding as well … [Read more…]

Rosen Law Firm Encourages Kairos Pharma, Ltd. Investors to Inquire About Securities Class Action Investigation – KAPA

NEW YORK–(BUSINESS WIRE)–Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Kairos Pharma, Ltd. (NYSE American: KAPA) resulting from allegations that Kairos Pharma may have issued materially misleading business information to the investing public. So what: If you purchased Kairos Pharma securities … [Read more…]

Ayco Farms Clarifies FDA Enforcement Report Listing: No Active Recall and No Product in Market

There is no active cantaloupe recall and no product in the marketplace POMPANO BEACH, Fla.–(BUSINESS WIRE)–Ayco Farms, Inc. (“Ayco Farms”) today issued a clarification regarding recent media coverage tied to its inclusion in the U.S. Food and Drug Administration’s weekly Enforcement Report. The listing reflects a previously completed, voluntary recall of fresh whole cantaloupes that … [Read more…]

Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting

MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the Infusion Nurses Society (INS) 2026 Annual Meeting taking place in Louisville, KY from April 11 – 14, 2026. The event will bring together leading clinicians, researchers, healthcare professionals and industry leaders all dedicated to … [Read more…]

ISG to Study Medical Device Digital Service Providers

Upcoming ISG Provider Lens® report will evaluate providers embedding AI-based capabilities into medical devices to improve patient care STAMFORD, Conn.–(BUSINESS WIRE)–$III #AI–Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has launched a research study examining service providers that help medical device companies adopt new technologies and enhance their products. … [Read more…]

MediStreams Achieves Clean SOC 2 Type II Certification, Strengthening Security in Healthcare Revenue Cycle Management and Payment Automation

Independent audit confirms controls over Security, Availability, and Processing Integrity operated effectively throughout 2025, demonstrating secure healthcare payment processing and remittance automation ATLANTA–(BUSINESS WIRE)–#CalmtheChaos—MediStreams, a leading healthcare revenue cycle management company specializing in automated payment posting and reconciliation, today announced the successful completion of its SOC 2 Type II examination for the period of January … [Read more…]

Verastem Oncology Announces Two-Year Median Follow-Up Data on AVMAPKI® FAKZYNJA® Combination Therapy (avutometinib capsules; defactinib tablets) in Recurrent Low-Grade Serous Ovarian Cancer at the SGO 2026 Annual Meeting on Women’s Cancers

Patients in the Phase 2 RAMP 201 clinical trial demonstrated sustained clinical benefits across multiple efficacy measures highlighting durability of response with a median follow-up of two years 52% of patients with a KRAS mutation and 30% of patients with KRAS wild-type recurrent LGSOC remained on therapy for more than one year After two years … [Read more…]

Prime Healthcare Services, Inc. Schedules 2026 1st Quarter Earnings Conference Call

ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will report earnings the morning of May 12th, 2026, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. To pre-register prior to the call, email EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. About Prime Healthcare … [Read more…]

Ossium Health Hosts Facility Tour and Reception for Indiana Governor Mike Braun and Healthcare Leaders

Indianapolis Biotech Marks Growing Milestone in the Fight Against Blood Cancer INDIANAPOLIS–(BUSINESS WIRE)–This week, Ossium Health hosted a facility tour and reception at its Indianapolis production facility, bringing together Indiana state officials and healthcare leaders to celebrate the company’s pioneering work in cell therapy and its contribution to Indiana’s growing biotech economy. Indiana Governor Mike … [Read more…]